Institutions / Avidity Partners Management LP / Holdings
Back to Avidity Partners Management LP

Avidity Partners Management LP

All holdings · as of Dec 31, 2025

39 positions

CompanyClassValueShares% of portfolio
Dianthus Therapeutics, Inc.—$86.71M2,104,18425.0%
CG Oncology, Inc.—$61.15M1,472,69917.6%
JADE BIOSCIENCES, INC.—$21.61M1,400,7086.2%
Oruka Therapeutics, Inc.—$20.02M660,4245.8%
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVAADR$13.02M417,3003.8%
BOSTON SCIENTIFIC CORP—$10.92M114,5003.1%
Medtronic plc—$10.34M107,6003.0%
Perspective Therapeutics, Inc.—$8.83M3,210,7332.5%
Alnylam Pharmaceuticals Inc—$8.35M21,0002.4%
REPLIGEN CORP—$8.24M50,3002.4%
Context Therapeutics Inc.—$8.09M5,504,8552.3%
MCKESSON CORP—$7.81M9,5202.3%
ICON plc—$6.03M33,1001.7%
Agilent Technologies Inc—$5.65M41,5001.6%
PFIZER INC—$5.07M203,6001.5%
Centene Corp—$4.91M119,4001.4%
Kenvue Inc.—$4.02M232,8001.2%
DANAHER CORP /DE—$3.89M17,0001.1%
THERMO FISHER SCIENTIFIC INC.—$3.88M6,7001.1%
NOVO-NORDISK A S—$3.42M67,3001.0%
Phathom Pharmaceuticals, Inc.PHATCommon Stock$3.42M206,0761.0%
Encompass Health Corp—$3.35M31,6001.0%
Cigna Group—$3.19M11,6000.9%
Cencora Inc—$3.17M9,4000.9%
INSMED INC—$3.08M17,7000.9%
Waters Corp—$3.08M8,1000.9%
ACADIA Pharmaceuticals Inc—$2.86M106,9000.8%
GENMAB A/S—$2.83M92,0000.8%
Natera, Inc.—$2.70M11,8000.8%
Immunic, Inc.—$2.51M4,699,4110.7%
Acadia Healthcare Company, Inc.—$2.40M169,0000.7%
Integer Holdings Corp—$2.34M29,8000.7%
Enliven Therapeutics, Inc.ELVNCommon Stock$2.16M140,3000.6%
PALVELLA THERAPEUTICS, INC.PVLACommon Stock$2.02M19,3000.6%
HEALTHEQUITY, INC.—$1.55M16,9000.4%
SCYNEXIS, Inc.—$1.32M2,081,6600.4%
IQVIA HOLDINGS INC.—$991.8K4,4000.3%
Karyopharm Therapeutics Inc.—$990.4K134,5660.3%
CORCEPT THERAPEUTICS INC—$765.6K22,0000.2%
← PrevPage 1 of 1Next →